Original Research
Accepted on 29 Jan 2026
LITAF suppresses breast cancer and paclitaxel resistance by ubiquitinating and degrading PCMT1 to inhibit COX-2-dependent arachidonic acid metabolism
- 146 views
Original Research
Accepted on 29 Jan 2026
Original Research
Accepted on 29 Jan 2026
Original Research
Accepted on 29 Jan 2026
Review
Accepted on 29 Jan 2026
Original Research
Accepted on 29 Jan 2026
Original Research
Accepted on 29 Jan 2026
Mini Review
Published on 29 Jan 2026
Systematic Review
Published on 29 Jan 2026
Correction
Published on 29 Jan 2026
Editorial
Published on 29 Jan 2026
Retraction
Published on 29 Jan 2026
Original Research
Published on 29 Jan 2026
Mini Review
Published on 29 Jan 2026
Review
Published on 29 Jan 2026
Review
Published on 29 Jan 2026
Case Report
Published on 29 Jan 2026
Review
Published on 29 Jan 2026
Brief Research Report
Published on 29 Jan 2026
Retraction
Published on 29 Jan 2026
Review
Published on 29 Jan 2026
Review
Published on 29 Jan 2026
Systematic Review
Published on 29 Jan 2026
Original Research
Published on 29 Jan 2026
Original Research
Published on 29 Jan 2026